• Patient
  • Klinische Anwender
  • Forschungs Anwender
  • Über uns
Vivosight (Deutsch)
  • VivoSight-Scanner
    • Funktion
    • Häufig gestellte fragen
  • Untersuchungsablauf
  • Hautkrebs
    • Daten und Fakten
  • Kontakt
    • Scanner in Ihrer Nähe
  • Search
▼International (DE)
International (EN)
United States

Optical Coherence Tomography for Presurgical Margin Assessment of Non-melanoma Skin Cancer – A Practical Approach

Alawi S A, Kuck M, Wahrlich C, Batz S, McKenzie G, Fluhr J W, Lademann J, Ulrich M./Exp Dermatol./14th August 2013
Read more →

In Vivo Optical Coherence Tomography (OCT) in Periocular Basal Cell Carcinoma: Correlations between In Vivo OCT Images and Postoperative Histology

Pelosini L, Smith HB, Schofield JB, Meeckings A, Dhital A, Khandwala M./Br J Ophthalmol. /15th May 2013
Read more →

Optical Coherence Tomography–Based Optimization of Mohs Micrographic Surgery of Basal Cell Carcinoma: A Pilot Study

Wang K. X, Meekings A, Fluhr JW, McKenzie G, Lee DA, Fisher J, Markowitz O, Siegel D. M./Dermatol Surg./22nd April 2013
Read more →

Optical Coherence Tomography and Its Role in Mohs Micrographic Surgery: A Case Report

Chan, S, Rohrer, T./Case Rep Dermatol./20th December 2012
Read more →

Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery

Pomerantz R. G, Zell D, McKenzie G, Siegel D. M./Case Rep Dermal./30th September 2011
Read more →

Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery

Cunha D, Richardson T, Sheth N, Orchard G, Coleman A, Mallipeddi R. /Br J Dermatol./28th July 2011
Read more →

Recent Posts

  • (no title)
  • (no title)
  • (no title)
  • (no title)
  • (no title)

Categories

  • Appointments
  • Autoimmun-Erkrankungen
  • Clinical Evidence
  • Corporate
  • Corporate
  • Entzündliche Erkrankungen
  • Events
  • Financing
  • Klinische Anwendung
  • Media Coverage
  • Nagelpilz und Erkrankungen des Nagelapparates
  • News
  • Nicht-melanozytäre Haut-Tumore und aktinische Keratose
  • OCT
  • Präoperative Tumorrand-Bestimmung
  • Press Release
  • Uncategorised
  • VivoSight
  • VivoSight
  • Weitere Anwendungen in der Dermatologie und Übersichtsartikel
  • Wundheilung, Narben und Verbrennungen

MICHELSON DIAGNOSTICS

Über uns
Karriere
Das Team
Aktuelles

 

 

KONTAKT

Agentur:
DermoScan GmbH
Ohmstraße 1, D-93055 Regensburg

T: +49 (0) 941 599 525 0
F: +49 (0) 32 211089 90002

E: info.de@vivosight.com

LEGAL

Impressum
Datenschutzerklärung
Cookie policy

Scroll to top